NEBBII MOLECULAR DELIVERY SYSTEM Trademark

Trademark Overview


On Monday, December 28, 2020, a trademark application was filed for NEBBII MOLECULAR DELIVERY SYSTEM with the United States Patent and Trademark Office. The USPTO has given the NEBBII MOLECULAR DELIVERY SYSTEM trademark a serial number of 90420993. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, March 9, 2023. This trademark is owned by Lynxco Group LLC. The NEBBII MOLECULAR DELIVERY SYSTEM trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Natural supplements for treating depression and anxiety; any CBD in the goods being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis

Medical apparatus for facilitating the inhalation of pharmaceutical preparations; any CBD in the pharmaceutical preparations being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis
nebbii molecular delivery system

General Information


Serial Number90420993
Word MarkNEBBII MOLECULAR DELIVERY SYSTEM
Filing DateMonday, December 28, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, March 9, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the word NEBBII in stylized format appearing above the words MOLECULAR DELIVERY SYSTEM.
Name/Portrait Description and/or Consent StatementThe name(s), portrait(s), and/or signature(s) shown in the mark does not identify a particular living individual.
Goods and ServicesNatural supplements for treating depression and anxiety; any CBD in the goods being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis
Translation of Words in MarkThe wording NEBBII has no meaning in a foreign language.
Goods and ServicesMedical apparatus for facilitating the inhalation of pharmaceutical preparations; any CBD in the pharmaceutical preparations being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis
Disclaimer with Predetermined Text"MOLECULAR DELIVERY SYSTEM"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 18, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, March 18, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLynxco Group LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressQueen Creek, AZ 85142

Trademark Events


Event DateEvent Description
Thursday, March 9, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, March 9, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, March 9, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, August 25, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, August 25, 2022FINAL REFUSAL E-MAILED
Thursday, August 25, 2022FINAL REFUSAL WRITTEN
Tuesday, August 16, 2022ASSIGNED TO EXAMINER
Wednesday, August 10, 2022ASSIGNED TO EXAMINER
Friday, August 5, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 4, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 4, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 25, 2022ASSIGNED TO EXAMINER
Friday, February 4, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 4, 2022NON-FINAL ACTION E-MAILED
Friday, February 4, 2022NON-FINAL ACTION WRITTEN
Tuesday, January 4, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 3, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 3, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 1, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 1, 2021NON-FINAL ACTION E-MAILED
Thursday, July 1, 2021NON-FINAL ACTION WRITTEN
Thursday, June 24, 2021ASSIGNED TO EXAMINER
Thursday, March 18, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 31, 2020NEW APPLICATION ENTERED